Search details
1.
Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
Prev Med
; 160: 107096, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35594924
2.
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
Int J Cancer
; 148(2): 396-405, 2021 01 15.
Article
in English
| MEDLINE | ID: mdl-32997803
3.
Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review.
J Low Genit Tract Dis
; 25(1): 27-37, 2021 Jan 01.
Article
in English
| MEDLINE | ID: mdl-33105450
4.
Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework.
J Clin Microbiol
; 58(2)2020 01 28.
Article
in English
| MEDLINE | ID: mdl-31723012
5.
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
BMC Cancer
; 20(1): 396, 2020 May 06.
Article
in English
| MEDLINE | ID: mdl-32375689
6.
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort.
Int J Cancer
; 145(4): 1033-1041, 2019 08 15.
Article
in English
| MEDLINE | ID: mdl-30895602
7.
Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.
Int J Cancer
; 140(10): 2212-2219, 2017 05 15.
Article
in English
| MEDLINE | ID: mdl-28195317
8.
The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.
J Clin Microbiol
; 54(9): 2267-72, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27307461
9.
Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.
J Clin Microbiol
; 54(11): 2669-2675, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27535689
10.
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study.
BMC Cancer
; 16: 510, 2016 07 20.
Article
in English
| MEDLINE | ID: mdl-27439470
11.
Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.
BMC Cancer
; 15: 216, 2015 Apr 02.
Article
in English
| MEDLINE | ID: mdl-25886410
12.
Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology.
Gynecol Oncol
; 135(3): 474-80, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25449563
13.
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system.
BMC Infect Dis
; 14: 413, 2014 Jul 26.
Article
in English
| MEDLINE | ID: mdl-25064473
14.
Results from the SARS-CoV-2 wastewater-based surveillance system in Denmark, July 2021 to June 2022.
Water Res
; 252: 121223, 2024 Mar 15.
Article
in English
| MEDLINE | ID: mdl-38310802
15.
Construction of a gammaretrovirus with a novel tropism and wild-type replication kinetics capable of using human APJ as entry receptor.
J Virol
; 86(19): 10621-7, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22811542
16.
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
J Clin Pathol
; 76(3): 172-176, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-34782423
17.
Clinical Performance of the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework.
J Mol Diagn
; 24(4): 365-373, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35123039
18.
Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program.
Am J Clin Pathol
; 157(3): 390-398, 2022 Mar 03.
Article
in English
| MEDLINE | ID: mdl-34546350
19.
Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT framework.
J Virol Methods
; 292: 114118, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33766660
20.
The challenges of defining sample adequacy in an era of HPV based cervical screening.
J Clin Virol
; 137: 104756, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33662921